CTD stands for Common Technical Document, which is a standardized format for organizing and presenting data for regulatory submissions in the pharmaceutical industry. It was developed by the International Conference on Harmonisation (ICH) to streamline the drug approval process across different regulatory agencies worldwide.
The CTD structure consists of five modules that cover quality, safety, and efficacy information for drug products. This harmonized format facilitates efficient review by regulatory authorities and promotes consistency in drug applications across different countries and regions.
The CTD is crucial in clinical research as it provides a standardized framework for organizing and presenting data from drug development programs. This standardization enhances the efficiency of regulatory reviews, facilitating faster and more consistent drug approval processes across different regulatory agencies worldwide.
Furthermore, the CTD format ensures that all necessary information is included in regulatory submissions, reducing the likelihood of delays due to incomplete or poorly organized data. By adopting this globally recognized structure, pharmaceutical companies can streamline their development and submission processes, potentially accelerating the time-to-market for new therapies.
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…
Copyright @ 2026 Axcellant